Partial or complete regression of hyperprolactinemic amenorrhea-galactorrhea syndrome after bromocriptine-induced pregnancy. 1980

G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000568 Amenorrhea Absence of menstruation. Postpartum Amenorrhea,Amenorrhea, Postpartum,Postpartum Amenorrheas

Related Publications

G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
January 1977, The Journal of clinical endocrinology and metabolism,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
October 1978, Obstetrics and gynecology,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
November 1978, Ugeskrift for laeger,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
January 1967, Fertility and sterility,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
December 1975, Harefuah,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
December 1986, The Japanese journal of psychiatry and neurology,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
October 1977, La Nouvelle presse medicale,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
January 1984, Endokrynologia Polska,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
January 1984, Acta Europaea fertilitatis,
G M Molinatti, and C Campagnoli, and L Belforte, and F Massara, and C Peris, and N Pinna
January 1982, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Copied contents to your clipboard!